Psoriasis
Case Reports
Concurrent Atopic Dermatitis and Psoriasis Successfully Treated With Dual Biologic Therapy
Atopic dermatitis and psoriasis can coexist in a single patient, which may be suspected from a clinical picture of treatment-resistant disease, a...
From the Journals
Severe psoriasis linked to a higher risk for heart disease, study confirms
“We should diagnose and actively search for microvascular dysfunction in patients with psoriasis, as this population is at particularly high risk...
Original Research
Effect of COVID-19 Vaccination on Disease Severity in Patients With Stable Plaque Psoriasis: A Cross-sectional Study
Given the high risk for severe COVID infection in individuals with psoriasis who have comorbidities, vaccination with Covaxin and Covishield can...
Latest News
Medicare announces 10 drugs targeted for price cuts in 2026
People on Medicare may in 2026 see prices drop for 10 medicines, including pricey diabetes, cancer, blood clot, and arthritis treatments.
Latest News
Rheumatology trials seem vulnerable to unblinding: Report
In an analysis of 14 published randomized controlled clinical trials of common rheumatology drugs, most had a high estimated risk for inadvertent...
Original Research
Financial Insecurity Among US Adults With Psoriasis
The economic burden on patients with psoriasis has been rising over time, as the disease impacts many aspects of patients’ lives.
Latest News
New evidence suggests genetic risk factors in hidradenitis suppurativa
Two new studies provide better understanding of the genetic factors that may underlie pathogenesis of this inflammatory skin condition.
From the Journals
PsA biomarkers move researchers closer to predictive test
Researchers have identified 15 genes that may indicate which patients with psoriasis will develop psoriatic arthritis.
Latest News
Study validates use of new psoriatic arthritis prediction tool
To develop the tool, researchers evaluated 635 patients with psoriasis from a prospective longitudinal cohort study evaluating risk factors for...
Latest News
Roflumilast cream appears safe, effective for children with psoriasis, researchers report
In children aged 2-11 years, roflumilast cream 0.3% was well tolerated and improved signs and symptoms of psoriasis, researchers report.
Latest News
What factors cause multiple biologic failure in psoriasis?
“Prior cross-sectional and single-center studies have primarily analyzed therapeutic failure of a single biologic or biologics within one class,”...